[go: up one dir, main page]

AR077952A1 - RESISTANCE AGAINST OOMYCOTA IN PLANTS MEDIATED BY ANTIBODY FUSION - Google Patents

RESISTANCE AGAINST OOMYCOTA IN PLANTS MEDIATED BY ANTIBODY FUSION

Info

Publication number
AR077952A1
AR077952A1 ARP100103089A ARP100103089A AR077952A1 AR 077952 A1 AR077952 A1 AR 077952A1 AR P100103089 A ARP100103089 A AR P100103089A AR P100103089 A ARP100103089 A AR P100103089A AR 077952 A1 AR077952 A1 AR 077952A1
Authority
AR
Argentina
Prior art keywords
oomycota
resistance against
antibody fusion
fusion proteins
plants mediated
Prior art date
Application number
ARP100103089A
Other languages
Spanish (es)
Original Assignee
Fraunhofer Ges Forschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Forschung filed Critical Fraunhofer Ges Forschung
Publication of AR077952A1 publication Critical patent/AR077952A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Virology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Proteínas de fusion que comprenden proteínas o péptidos anti-oomicoticos unidos a un anticuerpo, o fragmento de éste, que reconoce específicamente un epítopo de un Oomycota. También se relaciona con polinucleotidos que codifican a las proteínas de fusion. Las formas de realizacion de la presente solicitud son especialmente utiles para proteger a las plantas contra Oomycota. La solicitud comprende, por lo tanto, plantas transgénicas que expresan las proteínas de fusion divulgadas.Fusion proteins comprising anti-oomicotic proteins or peptides bound to an antibody, or fragment thereof, that specifically recognizes an epitope of an Oomycota. It also relates to polynucleotides that encode fusion proteins. The forms of realization of the present application are especially useful for protecting plants against Oomycota. The application therefore includes transgenic plants that express the disclosed fusion proteins.

ARP100103089A 2009-08-24 2010-08-24 RESISTANCE AGAINST OOMYCOTA IN PLANTS MEDIATED BY ANTIBODY FUSION AR077952A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09168451 2009-08-24

Publications (1)

Publication Number Publication Date
AR077952A1 true AR077952A1 (en) 2011-10-05

Family

ID=42829976

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100103089A AR077952A1 (en) 2009-08-24 2010-08-24 RESISTANCE AGAINST OOMYCOTA IN PLANTS MEDIATED BY ANTIBODY FUSION

Country Status (8)

Country Link
US (1) US20120042416A1 (en)
EP (1) EP2478104A1 (en)
AR (1) AR077952A1 (en)
AU (1) AU2010288743A1 (en)
BR (1) BRPI1012085A2 (en)
CA (1) CA2754024A1 (en)
RU (1) RU2011133912A (en)
WO (1) WO2011023522A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105358698B (en) * 2013-04-29 2024-02-20 生物催化公司 Agrochemical compositions comprising antibodies binding to sphingolipids
EP3215624B1 (en) 2014-11-05 2023-11-29 Biotalys NV Transgenic plant comprising a polynucleotide encoding a variable domain of heavy-chain antibody
CN118146372A (en) 2018-05-08 2024-06-07 凡恩世制药(北京)有限公司 Anti-DLL 3 antibodies and uses thereof
CN116640222B (en) * 2022-02-16 2024-09-24 东莞市朋志生物科技有限公司 Antibody against 2,4-dinitrophenol, conjugate, reagent, kit and application thereof
CN118496353B (en) * 2024-06-05 2024-11-15 西藏自治区农牧科学院蔬菜研究所 Antibodies against phytophthora infestans Rpl16 protein and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2200434A1 (en) * 1994-09-19 1996-03-28 Jacob Bakker Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogensin crops
BR9915543A (en) 1998-10-16 2001-08-14 Fraunhofer Ges Forschung Resistance to plant diseases mediated by molecular pathogenicides
CA2482607C (en) 2002-04-22 2013-06-11 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi

Also Published As

Publication number Publication date
RU2011133912A (en) 2013-10-10
CA2754024A1 (en) 2011-03-03
BRPI1012085A2 (en) 2019-09-24
US20120042416A1 (en) 2012-02-16
AU2010288743A1 (en) 2011-09-01
EP2478104A1 (en) 2012-07-25
WO2011023522A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
BR112018071276A2 (en) anti-il-33 antibodies, compositions, methods and uses thereof
EA201591465A1 (en) SPECIFIC PLOTS FOR MODIFICATION OF ANTIBODIES FOR OBTAINING IMMUNOCONJUGATES
CO2018005436A2 (en) Antibodies and antibody fragments for site-specific conjugation
CY1122978T1 (en) ANTI-VLA-4 ANTIBODIES
CR20190227A (en) Bispecific heterodimeric fusion proteins containing il-15/il-15ralpha fc-fusion proteins and pd-1 antibody fragments
MX2020004503A (en) HUMANIZED OR CHIMERIC CD3 ANTIBODIES.
MX391989B (en) AMATOXIN AND ANTIBODIES CONJUGATES.
CO6602149A2 (en) Combined use of vip3ab and cry1fa for handling resistant insects
CO7250445A2 (en) St2 antigen binding proteins
CR20120210A (en) LINK PROTEINS TO THE ANTIGEN IL-23 HUMANS
EA201891093A1 (en) ANTIBODIES SPECIFICALLY BINDING PD-1 AND THEIR APPLICATION
MX2011011754A (en) COMPOSITIONS AND METHODS FOR ANTIBODIES THAT GO TO THE COMPLEMENT PROTEIN C3B.
GT201200132A (en) ANTAGONISTS IL-17A
EA201791693A1 (en) HETERODIMERNY IMMUNOHLOBULINS
PL3181581T3 (en) FcRn-Affinity Modified Antibodies That Aid Antigen Clearance
CL2012000254A1 (en) Isolated antigen-binding antibody that binds to b and t lymphocyte attenuating protein (btla); nucleic acid that encodes it; composition comprising said antibody; and expression vector.
BR112016022841A2 (en) j string modified
CR20130132A (en) METALPROTEASA-9 MATRIX ANTIBODIES
EA201491599A1 (en) ANTIBODIES TO MATRIX METALLOPROTEINASE 9
CL2014001123A1 (en) Anti-il 36r antibodies; pharmaceutical composition that contains it; isolated polynucleotide encoding the antibody; method for antibody production; diagnostic kit that contains it.
UY32501A (en) SPECIFIC ANTAGONIST ANTIBODY FOR ALFA4-BETA7 HETERODYMER
MX2022015258A (en) Anti-cxcr5 antibodies and compositions and uses thereof.
CR11434A (en) HUMAN ANTI-AMYLOID ANTIBODIES; COMPOSITIONS, METHODS AND USES
BRPI1016204A2 (en) antibody fusion proteins with modified fcrn binding sites
LT3325011T (en) PROTEIN FUSIONED FROM HUMAN PROTEIN FRAGMENTS TO DEVELOP REGULARLY MULTIMERIZED IMMUNOGLOBULIN FC COMPOSITIONS WITH INCREASED COMPLEMENT BINDING

Legal Events

Date Code Title Description
FB Suspension of granting procedure